RYPRX
Price
$9.77
Change
+$0.03 (+0.31%)
Updated
Apr 29 closing price
Net Assets
979.73M
VSCIX
Price
$103.95
Change
+$0.51 (+0.49%)
Updated
Apr 29 closing price
Net Assets
143.36B
Ad is loading...

RYPRX vs VSCIX

Header iconRYPRX vs VSCIX Comparison
Open Charts RYPRX vs VSCIXBanner chart's image
Royce Premier Invmt
Price$9.77
Change+$0.03 (+0.31%)
VolumeN/A
Net Assets979.73M
Vanguard Small Cap Index I
Price$103.95
Change+$0.51 (+0.49%)
VolumeN/A
Net Assets143.36B
RYPRX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYPRX vs. VSCIX commentary
May 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYPRX is a Buy and VSCIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 143B vs. RYPRX (980M). VSCIX pays higher dividends than RYPRX: VSCIX (1.53) vs RYPRX (0.01). RYPRX was incepted earlier than VSCIX: RYPRX (33 years) vs VSCIX (28 years). RYPRX (1.19) is less costly to investors than VSCIX (0.04). VSCIX is a more actively managed with annual turnover of: 13.00 vs. RYPRX (12.00). RYPRX has a lower initial minimum investment than VSCIX: RYPRX (2000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : -0.57 vs. RYPRX (-14.22). VSCIX return over 5 years is better than : 65.82 vs. RYPRX (-5.77).
RYPRXVSCIXRYPRX / VSCIX
Total Expense Ratio1.190.042,975%
Annual Report Gross Expense Ratio1.190.042,975%
Fund Existence33 years28 years-
Gain YTD-10.285-10.084102%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets980M143B1%
Annual Yield % from dividends0.011.531%
Returns for 1 year-14.22-0.572,514%
Returns for 3 years-13.0311.93-109%
Returns for 5 years-5.7765.82-9%
Returns for 10 years-50.0185.73-58%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KNSL434.6010.41
+2.45%
Kinsale Capital Group
WINT1.13-0.01
-0.88%
Windtree Therapeutics Inc.
CSTL19.85-0.24
-1.19%
Castle Biosciences
RAPT0.91-0.02
-1.64%
RAPT Therapeutics
BE18.91-0.33
-1.72%
Bloom Energy Corp